NeoGenomics, Inc. Cost of Revenue
NeoGenomics, Inc. (NEO) reported Cost of Revenue of $78.94 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2022-05-09
- NeoGenomics, Inc. cost of revenue for the quarter ending 2022-03-31 was $78.94M, a 6.73% increase year-over-year.
- NeoGenomics, Inc. cost of revenue for the quarter ending 2021-09-30 was $74.10M, a 3.81% increase year-over-year.
- NeoGenomics, Inc. cost of revenue for the quarter ending 2021-06-30 was $68.73M, a 16.56% increase year-over-year.
- NeoGenomics, Inc. cost of revenue for the quarter ending 2021-03-31 was $73.96M, a 23.97% increase year-over-year.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month |
|---|---|---|---|
| 2022-03-31 | $78.94M 10-Q · filed 2022-05-09 | ||
| 2021-09-30 | $74.10M 10-Q · filed 2021-11-04 | $142.84M derived: sum of 2 quarters · filed 2021-11-04 | $216.79M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $68.73M 10-Q · filed 2021-08-09 | $142.69M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $73.96M 10-Q · filed 2022-05-09 | ||
| 2020-09-30 | $71.38M 10-Q · filed 2021-11-04 | $130.35M derived: sum of 2 quarters · filed 2021-11-04 | $190.01M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $58.97M 10-Q · filed 2021-08-09 | $118.63M 10-Q · filed 2021-08-09 | |
| 2020-03-31 | $59.66M 10-Q · filed 2021-05-06 | ||
| 2019-09-30 | $53.84M 10-Q · filed 2020-10-29 | $106.59M derived: sum of 2 quarters · filed 2020-10-29 | $155.05M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $52.75M 10-Q · filed 2020-07-31 | $101.21M 10-Q · filed 2020-07-31 | |
| 2019-03-31 | $48.46M 10-Q · filed 2020-04-29 | ||
| 2018-09-30 | $36.77M 10-Q · filed 2019-11-13 | $73.99M derived: sum of 2 quarters · filed 2019-11-13 | $110.11M 10-Q · filed 2019-11-13 |
| 2018-06-30 | $37.22M 10-Q · filed 2019-08-07 | $73.34M 10-Q · filed 2019-08-07 | |
| 2018-03-31 | $36.12M 10-Q · filed 2019-05-08 | ||
| 2017-06-30 | $34.91M 10-Q · filed 2018-08-06 | $69.39M 10-Q · filed 2018-08-06 | |
| 2017-03-31 | $34.48M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |